
Marshall Wace’s Moderna MRNA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-35,200
| Closed | -$4.18M | – | 2590 |
|
2024
Q2 | $4.18M | Buy |
35,200
+26,300
| +296% | +$3.12M | 0.01% | 973 |
|
2024
Q1 | $948K | Sell |
8,900
-68,000
| -88% | -$7.25M | ﹤0.01% | 1465 |
|
2023
Q4 | $7.65M | Buy |
76,900
+71,142
| +1,236% | +$7.08M | 0.01% | 640 |
|
2023
Q3 | $595K | Sell |
5,758
-3,242
| -36% | -$335K | ﹤0.01% | 1396 |
|
2023
Q2 | $1.09M | Buy |
9,000
+6,839
| +316% | +$831K | ﹤0.01% | 1343 |
|
2023
Q1 | $332K | Sell |
2,161
-287,481
| -99% | -$44.2M | ﹤0.01% | 1786 |
|
2022
Q4 | $52M | Sell |
289,642
-380,659
| -57% | -$68.4M | 0.12% | 173 |
|
2022
Q3 | $79.3M | Buy |
670,301
+44,546
| +7% | +$5.27M | 0.17% | 107 |
|
2022
Q2 | $89.4M | Sell |
625,755
-183,380
| -23% | -$26.2M | 0.18% | 109 |
|
2022
Q1 | $139M | Buy |
809,135
+763,285
| +1,665% | +$131M | 0.26% | 68 |
|
2021
Q4 | $11.6M | Buy |
45,850
+42,828
| +1,417% | +$10.9M | 0.02% | 702 |
|
2021
Q3 | $1.16M | Buy |
3,022
+338
| +13% | +$130K | ﹤0.01% | 1491 |
|
2021
Q2 | $631K | Sell |
2,684
-67,483
| -96% | -$15.9M | ﹤0.01% | 1580 |
|
2021
Q1 | $9.19M | Sell |
70,167
-182,117
| -72% | -$23.8M | 0.04% | 454 |
|
2020
Q4 | $26.4M | Buy |
+252,284
| New | +$26.4M | 0.14% | 122 |
|
2020
Q3 | – | Sell |
-34,979
| Closed | -$2.25M | – | 1765 |
|
2020
Q2 | $2.25M | Buy |
+34,979
| New | +$2.25M | 0.02% | 725 |
|
2019
Q3 | – | Sell |
-114,512
| Closed | -$1.68M | – | 1791 |
|
2019
Q2 | $1.68M | Buy |
+114,512
| New | +$1.68M | 0.01% | 795 |
|